Evaluating Postoperative Narcotic Use in Prepectoral Versus Dual-plane Breast Reconstruction Following Mastectomy

Background:. The majority of postmastectomy breast reconstruction performed in the United States is device-based. Typically, a tissue expander or implant is placed in the dual-plane (ie, subpectoral). Prepectoral breast reconstruction with acellular dermal matrices following mastectomy is a relative...

Full description

Bibliographic Details
Main Authors: Libby R. Copeland-Halperin, MD, Louisa Yemc, PA-C, Erica Emery, MS, Devon Collins, MPH, Chang Liu, PhD, Ali N. Mesbahi, MD, FACS, Mark L. Venturi, MD, FACS
Format: Article
Language:English
Published: Wolters Kluwer 2019-02-01
Series:Plastic and Reconstructive Surgery, Global Open
Online Access:http://journals.lww.com/prsgo/fulltext/10.1097/GOX.0000000000002082
_version_ 1818889076361658368
author Libby R. Copeland-Halperin, MD
Louisa Yemc, PA-C
Erica Emery, MS
Devon Collins, MPH
Chang Liu, PhD
Ali N. Mesbahi, MD, FACS
Mark L. Venturi, MD, FACS
author_facet Libby R. Copeland-Halperin, MD
Louisa Yemc, PA-C
Erica Emery, MS
Devon Collins, MPH
Chang Liu, PhD
Ali N. Mesbahi, MD, FACS
Mark L. Venturi, MD, FACS
author_sort Libby R. Copeland-Halperin, MD
collection DOAJ
description Background:. The majority of postmastectomy breast reconstruction performed in the United States is device-based. Typically, a tissue expander or implant is placed in the dual-plane (ie, subpectoral). Prepectoral breast reconstruction with acellular dermal matrices following mastectomy is a relatively new technique that has favorable outcomes with minimal complications and satisfactory aesthetic results. Few studies have compared opioid use between the 2 approaches. This study compares duration of postoperative opioid use among patients undergoing prepectoral device-based breast reconstruction with those in whom dual-plane devices were placed. Methods:. We reviewed the records of adult female patients aged 18 years or older who underwent prepectoral or dual-plane device-based breast reconstructions following mastectomy by one of the 2 plastic surgeons (A.M. or M.V.) from 2015 to 2017 at a large tertiary care hospital. Patients with a history of substance abuse, chronic pain, or who were already receiving opioid medication were excluded. Electronic medical records were reviewed and patient surveys were conducted during postoperative visits to determine postoperative opioid requirements. Results:. During the study period, 58 patients underwent dual-plane breast reconstruction and 94 underwent prepectoral reconstruction. Demographics and comorbidities of the groups were similar. By multivariate regression analysis, the prepectoral reconstruction group required 33% fewer days on opioid analgesic medication (P = 0.016) and were 66% less likely to require opioid prescription refills (P = 0.027). There were no statistically significant differences in other outcomes or complications. Conclusion:. Patients undergoing prepectoral tissue expander or implant-based reconstruction required fewer days of opioid pain medication than those managed with the dual-plane technique.
first_indexed 2024-12-19T17:03:16Z
format Article
id doaj.art-ab97e2470a6a4a28a9f9253a7214b030
institution Directory Open Access Journal
issn 2169-7574
language English
last_indexed 2024-12-19T17:03:16Z
publishDate 2019-02-01
publisher Wolters Kluwer
record_format Article
series Plastic and Reconstructive Surgery, Global Open
spelling doaj.art-ab97e2470a6a4a28a9f9253a7214b0302022-12-21T20:13:14ZengWolters KluwerPlastic and Reconstructive Surgery, Global Open2169-75742019-02-0172e208210.1097/GOX.0000000000002082201902000-00006Evaluating Postoperative Narcotic Use in Prepectoral Versus Dual-plane Breast Reconstruction Following MastectomyLibby R. Copeland-Halperin, MD0Louisa Yemc, PA-C1Erica Emery, MS2Devon Collins, MPH3Chang Liu, PhD4Ali N. Mesbahi, MD, FACS5Mark L. Venturi, MD, FACS6From the *Inova Fairfax Medical Campus, Falls Church, Va.†National Center for Plastic Surgery, McLean, Va.From the *Inova Fairfax Medical Campus, Falls Church, Va.From the *Inova Fairfax Medical Campus, Falls Church, Va.From the *Inova Fairfax Medical Campus, Falls Church, Va.†National Center for Plastic Surgery, McLean, Va.†National Center for Plastic Surgery, McLean, Va.Background:. The majority of postmastectomy breast reconstruction performed in the United States is device-based. Typically, a tissue expander or implant is placed in the dual-plane (ie, subpectoral). Prepectoral breast reconstruction with acellular dermal matrices following mastectomy is a relatively new technique that has favorable outcomes with minimal complications and satisfactory aesthetic results. Few studies have compared opioid use between the 2 approaches. This study compares duration of postoperative opioid use among patients undergoing prepectoral device-based breast reconstruction with those in whom dual-plane devices were placed. Methods:. We reviewed the records of adult female patients aged 18 years or older who underwent prepectoral or dual-plane device-based breast reconstructions following mastectomy by one of the 2 plastic surgeons (A.M. or M.V.) from 2015 to 2017 at a large tertiary care hospital. Patients with a history of substance abuse, chronic pain, or who were already receiving opioid medication were excluded. Electronic medical records were reviewed and patient surveys were conducted during postoperative visits to determine postoperative opioid requirements. Results:. During the study period, 58 patients underwent dual-plane breast reconstruction and 94 underwent prepectoral reconstruction. Demographics and comorbidities of the groups were similar. By multivariate regression analysis, the prepectoral reconstruction group required 33% fewer days on opioid analgesic medication (P = 0.016) and were 66% less likely to require opioid prescription refills (P = 0.027). There were no statistically significant differences in other outcomes or complications. Conclusion:. Patients undergoing prepectoral tissue expander or implant-based reconstruction required fewer days of opioid pain medication than those managed with the dual-plane technique.http://journals.lww.com/prsgo/fulltext/10.1097/GOX.0000000000002082
spellingShingle Libby R. Copeland-Halperin, MD
Louisa Yemc, PA-C
Erica Emery, MS
Devon Collins, MPH
Chang Liu, PhD
Ali N. Mesbahi, MD, FACS
Mark L. Venturi, MD, FACS
Evaluating Postoperative Narcotic Use in Prepectoral Versus Dual-plane Breast Reconstruction Following Mastectomy
Plastic and Reconstructive Surgery, Global Open
title Evaluating Postoperative Narcotic Use in Prepectoral Versus Dual-plane Breast Reconstruction Following Mastectomy
title_full Evaluating Postoperative Narcotic Use in Prepectoral Versus Dual-plane Breast Reconstruction Following Mastectomy
title_fullStr Evaluating Postoperative Narcotic Use in Prepectoral Versus Dual-plane Breast Reconstruction Following Mastectomy
title_full_unstemmed Evaluating Postoperative Narcotic Use in Prepectoral Versus Dual-plane Breast Reconstruction Following Mastectomy
title_short Evaluating Postoperative Narcotic Use in Prepectoral Versus Dual-plane Breast Reconstruction Following Mastectomy
title_sort evaluating postoperative narcotic use in prepectoral versus dual plane breast reconstruction following mastectomy
url http://journals.lww.com/prsgo/fulltext/10.1097/GOX.0000000000002082
work_keys_str_mv AT libbyrcopelandhalperinmd evaluatingpostoperativenarcoticuseinprepectoralversusdualplanebreastreconstructionfollowingmastectomy
AT louisayemcpac evaluatingpostoperativenarcoticuseinprepectoralversusdualplanebreastreconstructionfollowingmastectomy
AT ericaemeryms evaluatingpostoperativenarcoticuseinprepectoralversusdualplanebreastreconstructionfollowingmastectomy
AT devoncollinsmph evaluatingpostoperativenarcoticuseinprepectoralversusdualplanebreastreconstructionfollowingmastectomy
AT changliuphd evaluatingpostoperativenarcoticuseinprepectoralversusdualplanebreastreconstructionfollowingmastectomy
AT alinmesbahimdfacs evaluatingpostoperativenarcoticuseinprepectoralversusdualplanebreastreconstructionfollowingmastectomy
AT marklventurimdfacs evaluatingpostoperativenarcoticuseinprepectoralversusdualplanebreastreconstructionfollowingmastectomy